NR 508 (Advanced Pharmacology) Week 2 TD and Quiz. (30 Pages of Discusssion, References and Quiz Content).
Buy and Download >
CLICK ON THE PRODUCT INFORMATION URL FOR MORE ABOUT THE td.
PART 1: (Ch 17, 18, 21, 24, 52, 53) Cynthia is a 65-year-old African American female who presents to the clinic for a check-up. Her last examination was ~5 years ago. She has no specific, significant , or urgent complaint. She explains that her only issues are thirst, fatigue, and leg numbness and tingling, which is beginning to occur more often. You decide to do a physical exam, as well as draw labs and receive the following results: Social history: no smoking or alcohol consumption. Physical examination: GEN: well nourished, slightly obese female VS: BP 180/103 HR 73 RR 13 T 98.4 Weight 90 kg, Height 5’6” HEENT: PERRLA COR: RRR (regular rate & rhythm), NMRG (No murmur (valve), rub (friction/fluid around pericardium), gallop (valve)) CHEST: CTA NEURO: monofilament test shows decreased peripheral sensation EXT: normal • What are the major problems in this patient, and what diagnoses do these values indicate? • Additionally, what is your assessment and pharmacological plan for each of these problems including the medication, dose, and mechanism of action? Cynthia, a 55-year-old African American female, presents to the office with complaints of polydipsia, fatigue, and frequent leg numbness and tingling. Upon examination, Cynthia is found to have a BMI of 32, elevated blood pressure, and decreased peripheral sensation. Based on her physical exam, blood and urine lab work are ordered. Cynthia’s lab work and the physical exam reveal a number of issues including chronic kidney disease (CKD), hypertension (HTN) secondary to CKD, hyperthyroidism, diabetes mellitus type 2 (DM2) that is uncontrolled, diabetic peripheral neuropathy, hyperlipidemia, proteinuria, fatigue, polydipsia, and obesity. Cynthia’s major problems along with the pharmacological plan will be addressed below Chronic kidney disease, stage 3B (calculated GFR of 30mL/min/1.73 m2, Calculated creatinine clearance (CrCl) = 26-32 mL/min): Angiotensin-converting enzyme (ACE) inhibitors aid renal functions in hypertensive HTN, secondary to CKD: Weight loss via diet and exercise are a must. Approximately 80 to 85 percent of CKD patients also have HTN (Mann, 2016). Hyperthyroidism: This is a serious discussion that must be had with the patient, with the best options of treatment explained. DM2, uncontrolled: Weight loss via diet and exercise are a must. Hyperlipidemia, possibly secondary to uncontrolled DM2: Diabetic peripheral neuropathy, secondary to DM2: Proteinuria: Mo